BioSpace News Archive

Certara®, the global model-informed drug development and decision support leader, today announced that the US Food and Drug Administration (FDA) has renewed its legacy licenses for Synchrogenix’s electronic Common Technical Document (eCTD) review software, GlobalSubmit REVIEW™ and GlobalSubmit VALIDATE™ for another year.

BioTalent Canada marked this year’s Global Biotech Week with the announcement of the release of their fifth annual National Compensation Guide for Canada’s bio-economy.

Vital Metrix, Inc. today announced that MedTech Breakthrough, an independent organization that recognizes the top companies and solutions in the global health and medical technology market, has selected the company as the winner of its “Best Biometric Sensor Solution” award in the 2019 MedTech Breakthrough Awards program.

Blade Therapeutics, a biopharmaceutical company advancing novel anti-fibrotic therapies, today announced the acquisition of ATXCo, Inc., including its core asset, PAT-409, a Phase I ready autotaxin inhibitor for patients with fibrotic diseases.

Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, today announced that it has applied the CE mark to the PGDx elio™ tissue complete assay.

The Hyundai Hope On Wheels non-profit embarks on a nationwide tour this September during Childhood Cancer Awareness Month to award new grants for pediatric cancer, surpassing $160 million in lifetime funding for research.

CVS Health announced that MinuteClinic, the company’s retail medical clinic, joins a premier group of organizations that have received Pathway to Excellence® designation from the American Nurses Credentialing Center.

The article is published in Frontiers in Immunology and entitled “Absence of the Lectin Activation Pathway of Complement Ameliorates Proteinuria-Induced Renal Injury,”

Combe, Inc., the makers of Vagisil®, announced a partnership with Power to Decide, the campaign to prevent unplanned pregnancy, to provide low-income women access to contraception.

Nanosonics (ASX: NAN), a leader in infection prevention solutions, will sponsor a symposium on change management and standardization in probe reprocessing at the Society of Diagnostic Medical Sonography (SDMS) Annual Conference